BUCOLOME, A POTENT BINDING INHIBITOR FOR FUROSEMIDE, ALTERS THE PHARMACOKINETICS AND DIURETIC EFFECT OF FUROSEMIDE: POTENTIAL FOR USE OF BUCOLOME TO RESTORE DIURETIC RESPONSE IN NEPHROTIC SYNDROME-Reference-Cited by-同舟云学术

BUCOLOME, A POTENT BINDING INHIBITOR FOR FUROSEMIDE, ALTERS THE PHARMACOKINETICS AND DIURETIC EFFECT OF FUROSEMIDE: POTENTIAL FOR USE OF BUCOLOME TO RESTORE DIURETIC RESPONSE IN NEPHROTIC SYNDROME

Published:2005-01-07 Issue:4 Volume:33 Page:596-602
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Takamura Norito,Maruyama Toru,Chosa Etsuo,Kawai Keiichi,Tsutsumi Yasuhiro,Uryu Yukie,Yamasaki Keishi,Deguchi Tsuneo,Otagiri Masaki

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference28 articles.

1. Urinary Protein Binding Does Not Affect Response to Furosemide in Patients with Nephrotic Syndrome

2. Study of interactions between ibuprofen and sulfonamides, and between bucolome and sulfonamides in rats.

3. Resistance of proteinuric rats to furosemide: Urinary drug protein binding as a determinant of drug effect

4. Effect of 5-n-Butyl-1-cyclohexyl-2, 4, 6-trioxoperhydropyrimidine on the Sulfonamides Transfer in the Rat

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A mini review on human serum albumin - natural alkaloids interaction and its role as drug carrier;Journal of Biomolecular Structure and Dynamics;2024-02-12

2. Evaluation of the effect of phenylpropanoids on the binding of heparin to human serum albumin and glycosylated human serum albumin concerning anticoagulant activity: A comparison study;International Journal of Biological Macromolecules;2024-02

3. Superior Dialytic Removal of Bilirubin and Bile Acids by Free Fatty Acid Displacement and Its Synergy With Albumin-Based Dialysis;ASAIO Journal;2022-04-11

4. Hypoglycemia possibly caused by CYP2C9-mediated drug interaction in combination with bucolome: a case report;Journal of Pharmaceutical Health Care and Sciences;2021-11-03

5. Serum protein-based nanoparticles for cancer diagnosis and treatment;Journal of Controlled Release;2021-01